Biography

Alla Digilova is a partner in the Capital Markets and Securities Practice Group in Haynes Boone’s New York office.

Alla Digilova focuses her practice on capital markets transactions, securities regulation, and corporate governance, advising public and private companies, investment banks, and institutional investors. Alla’s extensive experience spans a wide range of public and private securities offerings, including initial and secondary offerings of equity and convertible securities, “at-the market” offerings, rights offerings, registered direct offerings, high-yield and investment debt offerings, and private investments in public equity (PIPEs). Alla also advises clients on corporate transactions of varying complexity, including cross-border listings, mergers and acquisitions, reverse mergers, de-SPAC transactions, spin-offs, and direct listings. In addition, Alla serves as outside counsel to numerous public company clients with respect to corporate governance issues, compliance with NYSE and NASDAQ requirements, SEC reporting and compliance with the U.S. federal securities laws, as well as general corporate matters.

Alla's clients come from a diverse set of industries, including life sciences, mining, consumer goods, and technology. Her market-leading work has earned her recognition as a "Rising Star" in Securities and Corporate Governance by Super Lawyers in 2024 and the ABA's “Top 40 Young Lawyers” Award in 2024.

Alla is actively involved in community and professional initiatives, serving on the board of Harvard Law School Association of New York, the board of COJECO (Council of Jewish Émigré Community Organizations), and the Editorial Board of Women Lawyers Journal of National Association of Women Lawyers.

Alla earned her law degree from Harvard Law School, where she served as the Legal Fellow at Multi-Regional Clinical Trials Center at Harvard University and a Board Member of Harvard Law and International Development Society.

Expand All

Equity Offerings

  • AYRO, Inc., a designer and manufacturer of electric, purpose-built delivery vehicles, in $22 million private placement of preferred stock and common warrants.
  • Wrap Technologies, Inc., a public safety technology and services company, in $10 million registered direct offering of preferred stock and common warrants.
  • Uranium Royalty Corp., a uranium royalty company, in $40 million at-the-market equity program.
  • VBI Vaccines Inc., a biopharmaceutical company, in $18 million underwritten public offering of common shares and $3 million concurrent registered direct offering.
  • H.C. Wainwright & Co. as placement agent in numerous registered offerings.
  • Iconic Sports Acquisition Corp., a special purpose acquisition company, in $345 million initial public offering.
  • BTIG, LLC in $200 million initial public offering of SHUAA Partners Acquisition Corp I, a special purpose acquisition company focusing on the technology and/or tech-enabled financial services sectors.
  • J.P. Morgan Securities LLC and Cowen and Company, LLC in $200 million initial public offering of DA32 Life Sciences Tech Acquisition Corp., a special purpose acquisition company focusing on promising opportunities in the life science technology sector.

Mergers & Acquisitions

  • BiomX Inc. in its merger with Adaptive Phage Therapeutics, Inc. and the concurrent $50 million private placement financing.
  • Firefly Neuroscience, Inc., a medical technology company, in its reverse merger with WaveDancer, Inc.
  • L&F Acquisition Corp., a special purpose acquisition company, in its $1.4 billion business combination with ZeroFox and IDX.
  • Montes Archimedes Acquisition Corp., a special purpose acquisition company, in its $7.3 billion business combination with Roivant Sciences.
  • Atlas Crest Investment Corp., a special purpose acquisition company, in its $1.7 billion business combination with Archer Aviation.
  • Leo Holdings III Corp., a special purpose acquisition company, on its $1.1 billion merger with Local Bounti.
  • Horizon Acquisition Corp., a special purpose acquisition company, in its $1.95 billion business combination with Vivid Seats Inc.

Notes Offerings

  • Certain funds affiliated with The Carlyle Group Inc. in connection with the exchange of $125,000,000 of 4.25% senior convertible notes due 2023 of Seacor Marine Holdings, Inc. held by the funds for (i) $90,000,000 8.0% / 9.5% senior PIK toggle notes due 2026 and (ii) $35,000,000 4.25% convertible senior notes due 2026.
  • Investor group led by Advent International Corporation and Permira Advisers LLC in $2 billion 144A notes offerings for the acquisition of McAfee Corp. (NASDAQ: MCFE), a global leader in online protection.
  • RBC Bearings Incorporated, an international manufacturer and marketer of highly engineered precision bearings and products, in connection with its $1.1 billion concurrent offerings of common stock and mandatory convertible preferred stock and offering of $500 million of unsecured high yield notes.
  • Intelsat Jackson Holdings S.A.,  operator of the world’s largest integrated satellite and terrestrial network and leading provider of inflight connectivity services, in its private placement of $3 billion high-yield senior notes in connection with its Chapter 11 case

*Some of these representations were handled by Alla prior to joining Haynes Boone.

  • New York State Bar Association
    • Member, Securities Regulation Committee
    • Member, Women in the Association Committee
  • Member, UJA Federation of New York, FSU Board
  • Board Member, Harvard Law School Association of New York City
  • Member, Editorial Board of National Association of Women Lawyers Journal
  • Selected as 2024 American Bar Association On the Rise - Top 40 Young Lawyer
  • Selected for inclusion in New York Super Lawyers Rising Stars, Thomson Reuters, for Securities and Corporate Finance, 2024
  • "8 Tips On Mining Disclosures For Foreign Issuers," co-author, Law360, November 6, 2023.
  • “Incorporating Ethical Principles into Clinical Research Protocols: A Tool for Protocol Writers and Ethics Committees,” co-author, Journal of Medical Ethics, 2016.
  • "Global Trends Toward Transparency in Participant-Level Clinical Trials Data,” in FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies," co-author, Columbia University Press, 2015.
  • “A Comprehensive Approach to Conditional Cash Transfers,” co-author, 22 Georgetown Journal on Poverty Law & Policy 1, Fall 2014.

Education

J.D., Harvard Law School, 2014, Harvard Journal of Law and Technology

B.A., Biology & Economics, Yeshiva University, 2010, summa cum laude, S. Daniel Abraham Honors Program, Anne Scheiber Scholar

Languages

Russian

Admissions

New York